Account
Insider Insights
28.02.2022
UK first rare disease action plan

On 28th February 2022, Health and Social Care Secretary Sajid Javid launched England’s first Rare...

Read more
Insider Insights
24.02.2022
Legislation-extends-CPR-and-CTS-membership

The National Recovery and Resilience Plan had extended the membership to the CPR and CTS until 28th...

Read more
Insider Insights
21.02.2022
CNAM spending on reimbursed medicines

Reimbursed spending by the CNAM on out-patient care (including care from general practitioners [GPs]...

Read more
Insider Insights
21.02.2022
Eligibility for prescribing testosterone

The change is intended to simplify care pathways and the management of patients requiring testoster...

Read more
Insider Insights
18.02.2022
Pharmacy chains reduce price of contraceptive pill

Superdrug has reduced the price of a generic version of the emergency hormonal contraceptive pill (l...

Read more
Insider Insights
17.02.2022
Analysis of top ten therapeutic groups dispensed

In terms of volume, proton pump inhibitors were the top-selling therapeutic group (at ATC-level 4) w...

Read more
Insider Insights
17.02.2022
Paracetamol and Ibuprofen combination available

The switch from prescription to non-prescription status was recommended by the Federal Institute for...

Read more
Insider Insights
16.02.2022
AIFA announces reimbursement of oral SMA treatment

The Italian Medicines Agency (AIFA) has announced that Roche’s Evyrsdi (risdiplam) is reimbursed w...

Read more
Insider Insights
15.02.2022
NICE recommends CDF use of dostarlimab

The CDF allows patients to access a new treatment while further data is collected on its clinical an...

Read more
Insider Insights
14.02.2022
Fall in wholesale margins on prescription drugs

Wholesale margins on prescription drugs fell to 3.99% in 2021 (down from 4.09% in the previous year)...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.